These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30471340)
1. Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients. Faraci M; Calevo MG; Giardino S; Leoni M; Ricci E; Castagnola E; Lanino E Biol Blood Marrow Transplant; 2019 Apr; 25(4):743-748. PubMed ID: 30471340 [TBL] [Abstract][Full Text] [Related]
2. A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation. Khandelwal P; Emoto C; Fukuda T; Vinks AA; Neumeier L; Dandoy CE; El-Bietar J; Chandra S; Davies SM; Bleesing JJ; Jordan MB; Mehta PA; Jodele S; Grimley MS; Kumar A; Myers KC; Marsh RA Biol Blood Marrow Transplant; 2016 Dec; 22(12):2220-2225. PubMed ID: 27664325 [TBL] [Abstract][Full Text] [Related]
3. Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience. De Jong CN; Saes L; Klerk CPW; Van der Klift M; Cornelissen JJ; Broers AEC PLoS One; 2017; 12(10):e0187184. PubMed ID: 29073260 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Chen X; Wang C; Yin J; Xu J; Wei J; Zhang Y PLoS One; 2015; 10(8):e0136991. PubMed ID: 26323092 [TBL] [Abstract][Full Text] [Related]
5. Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease. van Groningen LF; Liefferink AM; de Haan AF; Schaap NP; Donnelly JP; Blijlevens NM; van der Velden WJ Biol Blood Marrow Transplant; 2016 Jan; 22(1):179-82. PubMed ID: 26386320 [TBL] [Abstract][Full Text] [Related]
6. Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease. Rashidi A; DeFor TE; Holtan SG; Blazar BR; Weisdorf DJ; MacMillan ML Biol Blood Marrow Transplant; 2019 Nov; 25(11):2297-2302. PubMed ID: 31325587 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185 [TBL] [Abstract][Full Text] [Related]
8. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study. Tan Y; Xiao H; Wu D; Luo Y; Lan J; Liu Q; Yu K; Shi J; He J; Zheng W; Lai X; Zhu Y; Du K; Ye Y; Zhao Y; Zheng G; Hu Y; Han X; Zheng Y; Wei G; Cai Z; Huang H Oncoimmunology; 2017; 6(3):e1277307. PubMed ID: 28405499 [TBL] [Abstract][Full Text] [Related]
9. Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children. Kurtzberg J; Prockop S; Chaudhury S; Horn B; Nemecek E; Prasad V; Satwani P; Teira P; Hayes J; Burke E; Biol Blood Marrow Transplant; 2020 May; 26(5):855-864. PubMed ID: 32044400 [TBL] [Abstract][Full Text] [Related]
10. Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation. Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y Biol Blood Marrow Transplant; 2020 Feb; 26(2):351-357. PubMed ID: 31704470 [TBL] [Abstract][Full Text] [Related]
11. [Anti-CD(25) monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease in 80 patients receiving allogeneic hematopoietic stem cell transplantation]. Tao T; Xue SL; Chen F; Xu Y; Ma X; Miao M; Tang XW; Wu DP Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):324-329. PubMed ID: 29747286 [No Abstract] [Full Text] [Related]
12. Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience. Yucebay F; Matthews C; Puto M; Li J; William B; Jaglowski SM; Penza SL; Vasu S; Benson DM; Andritsos LA; Devine SM; Efebera YA; Roddy JVF Leuk Lymphoma; 2019 Sep; 60(9):2223-2229. PubMed ID: 30764681 [TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC. Laisne L; Neven B; Dalle JH; Galambrun C; Esvan M; Renard C; Rialland F; Sirvent A; Gandemer V; Pediatr Blood Cancer; 2020 Sep; 67(9):e28233. PubMed ID: 32614145 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Busca A; Locatelli F; Marmont F; Ceretto C; Falda M Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391 [TBL] [Abstract][Full Text] [Related]
15. Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. Xhaard A; Rocha V; Bueno B; de Latour RP; Lenglet J; Petropoulou A; Rodriguez-Otero P; Ribaud P; Porcher R; Socié G; Robin M Biol Blood Marrow Transplant; 2012 Mar; 18(3):406-13. PubMed ID: 21736868 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Inagaki J; Kodama Y; Fukano R; Noguchi M; Okamura J Pediatr Transplant; 2015 Sep; 19(6):652-8. PubMed ID: 26103520 [TBL] [Abstract][Full Text] [Related]
17. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Ball LM; Bernardo ME; Roelofs H; van Tol MJ; Contoli B; Zwaginga JJ; Avanzini MA; Conforti A; Bertaina A; Giorgiani G; Jol-van der Zijde CM; Zecca M; Le Blanc K; Frassoni F; Egeler RM; Fibbe WE; Lankester AC; Locatelli F Br J Haematol; 2013 Nov; 163(4):501-9. PubMed ID: 23992039 [TBL] [Abstract][Full Text] [Related]
18. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Khoury H; Kashyap A; Adkins DR; Brown RA; Miller G; Vij R; Westervelt P; Trinkaus K; Goodnough LT; Hayashi RJ; Parker P; Forman SJ; DiPersio JF Bone Marrow Transplant; 2001 May; 27(10):1059-64. PubMed ID: 11438821 [TBL] [Abstract][Full Text] [Related]
19. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation. Minculescu L; Kornblit BT; Friis LS; Schiødt I; Petersen SL; Andersen NS; Sengeloev H Biol Blood Marrow Transplant; 2018 Mar; 24(3):600-607. PubMed ID: 29074374 [TBL] [Abstract][Full Text] [Related]